Motor stimulant effects of the adenosine A2A receptor antagonist SCH 58261 do not develop tolerance after repeated treatment in 6-hydroxydopamine-lesioned rats

Synapse

Volumn 39, Issue 3, 2001, Pages 233-238

  Pinna, Annalisa ^a   Fenu, Sandro ^a   Morelli, Micaela ^a  

^a UNIVERSITY OF CAGLIARI   (Italy)

Author keywords

Dyskinesia; L dopa (L 3,4 dihydroxyphenylalanine); Parkinson's disease; Repeated treatment; Turning behavior

Indexed keywords

5 AMINO 2 (2 FURYL) 7 (2 PHENYLETHYL)PYRAZOLO[4,3 E][1,2,4]TRIAZOLO[1,5 C]PYRIMIDINE; ADENOSINE A2A RECEPTOR; LEVODOPA; OXIDOPAMINE;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; DRUG POTENTIATION; DRUG REEXPOSURE; DRUG TOLERANCE; FOREBRAIN; MALE; MOTOR ACTIVITY; NIGRONEOSTRIATAL SYSTEM; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; RAT;

ANIMALS; DOPAMINE AGENTS; DRUG TOLERANCE; LEVODOPA; MALE; MOTOR ACTIVITY; NEUROPROTECTIVE AGENTS; OXIDOPAMINE; PYRIMIDINES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, ADENOSINE A2A; RECEPTORS, PURINERGIC P1; STEREOTYPED BEHAVIOR; SYMPATHECTOMY, CHEMICAL; TRIAZOLES;

EID: 0035283648     PISSN: 08874476     EISSN: None     Source Type: Journal    
DOI: 10.1002/1098-2396(20010301)39:3<233::AID-SYN1004>3.0.CO;2-K     Document Type: Article

References (32)

1. 2A adenosine antagonists
2. Adenosine neuromodulation
3. 2A receptor antagonism potentiates L-DOPA induced turning behaviour and c-fos expression in 6-hydroxydopamine-lesioned rats
4. 2 receptors in rat striatal membranes
5. Adenosinedopamine receptor-receptor interactions as an integrative mechanism in the basal ganglia
6. 2 dopamine receptors in rat striatum
7. Adenosine receptors
8. Action of caffeine and theophyllamine on supersensitive dopamine receptors: Considerable enhancement of receptor response to treatment with DOPA and dopamine receptor agonists
9. Comparison of the behavioural effects of an adenosine A1/A2-receptor antagonist, CGS 5943A, and an A1-selective antagonist, DPCPX
10. 2A receptor antagonist in MPTP-treated monkeys
11. Characterisation of enhanced behavioural responses to L-DOPA following repeated administration in the 6-hydroxydopamine-lesioned rat model of Parkinson's's disease
12. CGS 15943, a non xanthine adenosine receptor antagonist: Effects on locomotor activity of non tolerant and caffeine-tolerant rats
13. 2A-selective agonist [3H]CGS 21680
14. 2A antagonist: A novel antiparkinsonian agent that does not provoke dyskinesia in parkinsonian monkeys
15. Studies with bromocriptine. III. Concomitant administration of caffeine to patients with idiopathic parkinsonism
16. The pharmacology of Parklnson's's disease therapy: An update
17. 1 receptor-mediated effects on c-fos expression
18. Potential role of adenosine therapy in pathological tremor disorders
19. 2A adenosine receptor antagonist, SCH 58216, in the rat
20. Time and dose dependence of the "priming" of the expression of dopamine receptor supersensitivity
21. 2 receptors stimulate c-fos expression in striatal neurons of 6-hydroxydopamine lesioned rats
22. Adenosine receptor subtypes: Characterization and therapeutic regulation
23. 2A receptors
24. Motor fluctuations in levodopa treated parkinsonian rats: Relation to lesion extent and treatment duration
25. 1 agonists in dopamine-denervated rats
26. 2A receptor antagonists as new agents for the treatment of Parkinson's's disease
27. 2 receptor (RDC8) is expressed by enkephalin but not by substance P neurons: An in situ hybridization histochemistry study
28. Unilateral 6-hydroxydopamine lesions of meso-striatal dopamine neurons and their physiological sequelae
29. Caffeine and the antiparkinsonian response to levodopa or piribedil
30. 2A receptors underlies the behavioural activating effect of caffeine and is associated with reduced expression of mRNA for NGFI-A and NGFI-B in caudate-putamen and nucleus accumbens
31. The stimulatory action and the development of tolerance to caffeine is associated with alterations in gene expression in specific brain regions